NOVEL USE OF IL-1β COMPOUNDS

PROBLEM TO BE SOLVED: To provide novel use of IL-1β-ligand/IL-1 receptor disrupting compounds in the treatment and/or prevention of auto-inflammatory syndromes.SOLUTION: The invention discloses novel use of IL-1β-ligand/IL-1 receptor disrupting compounds in the treatment and/or prevention of auto-in...

Full description

Saved in:
Bibliographic Details
Main Authors LOWE PHIL, WRIGHT TIMOTHY, JUNG THOMAS, MUNDEL TREVOR, GRAM HERMANN
Format Patent
LanguageEnglish
Japanese
Published 24.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PROBLEM TO BE SOLVED: To provide novel use of IL-1β-ligand/IL-1 receptor disrupting compounds in the treatment and/or prevention of auto-inflammatory syndromes.SOLUTION: The invention discloses novel use of IL-1β-ligand/IL-1 receptor disrupting compounds in the treatment and/or prevention of auto-inflammatory syndromes.SELECTED DRAWING: None 【課題】 自己炎症性症候群の処置および/または予防における、IL−1β−リガンド/IL−1受容体かく乱化合物の新規使用を提供すること。【解決手段】 自己炎症性症候群の処置および/または予防における、IL−1β−リガンド/IL−1受容体かく乱化合物の新規使用を見いだした。【選択図】なし
Bibliography:Application Number: JP20170151327